LUCD Stock Analysis: Buy, Sell, or Hold?
LUCD - Lucid Diagnostics Inc. Common Stock
$1.15
0.03 (2.68%)
▲
5d:
-8.0%
30d:
-20.14%
90d:
+5.5%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 13, 2026
Get Alerted When LUCD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LUCD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LUCD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LUCD is currently trading at $1.15, which is considered oversold relative to its 30-day fair value range of $1.24 to $1.46.
Technical Outlook: Technically, LUCD is in a strong uptrend. Immediate support is located at $1.09, while resistance sits at $1.41.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.95 (+243.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LUCD is in a strong uptrend. Immediate support is located at $1.09, while resistance sits at $1.41.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.95 (+243.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.24 -
$1.46
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 243.5% below Wall St target ($3.95)
- CAUTION: Recommendation downgraded due to -8.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.24 -
$1.46
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.09
Resistance Level
$1.41
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.22
Wall Street Target
$3.95
(+243.5%)
Revenue Growth (YoY)
25.6%
Share & Embed Analysis
Last updated: March 31, 2026 12:22 AM ET
Data refreshes hourly during market hours. Next update: 1:22 AM
Data refreshes hourly during market hours. Next update: 1:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUCD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 51 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 48 HOLD |
